Which neurotransmitters are affected by Filagra Oral Jelly ? | Forum

Filagra Oral Jelly contains sildenafil citrate as its active ingredient. Sildenafil citrate is a phosphodiesterase type 5 (PDE5) inhibitor, primarily used to treat erectile dysfunction (ED) in men. It works by blocking the enzyme phosphodiesterase type 5, which regulates blood flow in the penis. However, it doesn't directly affect neurotransmitters. Neurotransmitters are chemicals in the brain that transmit signals between neurons. Filagra Oral Jelly, by blocking PDE5, indirectly affects the nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway, which is involved in smooth muscle relaxation and vasodilation in the penis. This results in increased blood flow to the penis, facilitating the achievement and maintenance of an erection. While Filagra Oral Jelly primarily affects the NO-cGMP pathway, it's important to note that sildenafil citrate can have indirect effects on neurotransmitter activity, particularly in the central nervous system, which may contribute to some of its side effects, such as headache, dizziness, and changes in vision. However, its primary mechanism of action is related to its effects on the NO-cGMP pathway in the penis rather than direct modulation of neurotransmitters.